Affected Products
A. PENTAX VIDEO DUODENOSCOPE
PENTAX Medical has been working with the U.S. Food and Drug Administration ("FDA") as part of an industry-wide initiative to determine what additional steps, if any, could be undertaken to reduce the risk of infection in flexible endoscopes used for ERCP procedures. The updated reprocessing IFUs were developed after rigorous validation testing and ongoing discussions with FDA to further enhance the safety margin and show with a high degree of assurance that the updated reprocessing IFUs, when followed correctly, effectively clean and disinfect the duodenoscope.